Dunton Alan W
- SEC CIK
- 0001304773
In the past year, 1 open-market sale filing worth $260.0K and no purchases.
Current role at each company
- PTN Palatin Technologies IncDirectoras of Aug 5, 2026
- CRMD CorMedix Inc.Directoras of Jan 27, 2026
- OGEN Oragenics IncDirectoras of Dec 15, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $260.0K
- 1 filing
- Net
- −$260.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Dunton Alan W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRMD CorMedix Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 (view filing) | Dec 30, 2025 | 3 days | Dunton Alan WDirector | SSale | −20.0K | $13.00 | −$260.0K | −33.2%40.3K after | 10b5-1 |
| Sep 16, 2025 (view filing) | Sep 12 | 4 days | Dunton Alan WDirector | SSale | −10.0K | $13.13 | −$131.3K | −19.9%40.3K after | |
| Dec 18, 2023 (view filing) | Dec 14-15 | 4 days | Dunton Alan WDirector | PPurchase | +6.00K | $3.38 | +$20.3K | +64.9%15.3K after | 2 lots |
| May 18, 2023 (view filing) | May 17 | 1 day | Dunton Alan WDirector | PPurchase | +3.00K | $4.33 | +$13.0K | +48.0%9.25K after | Amended |
PTN Palatin Technologies Inc
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Dunton Alan WDirector | PPurchaseSeries D Preferred Stock | +200 | $20,000.00 | +$4.00M | +0.1%224.1K after | Price outlier |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Dunton Alan WDirector | PPurchase | +363.6K | $0.00 | $0 | –420.0K after | Derivative |
| Dec 6, 2023 (view filing) | Dec 4 | 2 days | Dunton Alan WDirector | SSale | −200 | $2.48 | −$495.98 | −0.4%45.1K after | 2 lots |
| Dec 23, 2022 (view filing) | Dec 21 | 2 days | Dunton Alan WDirector | SSale | −200 | $2.97 | −$594 | −0.5%41.4K after | |
| Jul 2, 2021 (view filing) | Jun 30 | 2 days | Dunton Alan WDirector | PPurchase | +20.0K | $0.62 | +$12.4K | +2.6%786.5K after | Amended2 lots |
OGEN Oragenics Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2024 (view filing)6:07 PM ET | Dec 6 | 3 days | Dunton Alan WDirector | SSale | −66 | $0.36 | −$23.76 | −0.3%25.6K after |